The combined revenue of three listed pharmaceutical companies in Nigeria rose by 58 percent within a year amid the surging prices of drugs.
The latest financial statements of Fidson Healthcare Plc, May & Baker Nigeria Plc, and MeCure Industries Plc show that their total revenue grew to N33.4
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Folake Balogun
Folake Balogun is a tech journalist covering Africa’s fast-growing digital economy with a strong focus on incisive analysis of startup trends, venture capital, and fintech innovation, while also exploring emerging technologies such as artificial intelligence and the future of connectivity by highlighting their economic and social impact.
